In the BioHarmony Drug Report Database

"Preview" Icon

Methsuximide

Celontin (methsuximide) is a small molecule pharmaceutical. Methsuximide was first approved as Celontin on 1982-01-01. It is used to treat absence epilepsy and epilepsy in the USA.

 

Trade Name

 

Celontin
 

Common Name

 

methsuximide
 

ChEMBL ID

 

CHEMBL697
 

Indication

 

absence epilepsy, epilepsy
 

Drug Class

 

Image (chem structure or protein)

Methsuximide structure rendering